Terms: = Sarcomas AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
145 results:
1. 68 Ga-Pentixafor PET/CT for in-vivo mapping of cxcr4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.
Jena SR; Watts A; Aggarwal P; Bachhal V; Kaur H; Dhingra K; Singh H; Bal A; Singh B
Nucl Med Commun; 2024 Mar; 45(3):229-235. PubMed ID: 38165171
[TBL] [Abstract] [Full Text] [Related]
2. Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of cxcr4/PI3K/AKT signaling.
Jiang Y; Gao Y; Li X; He F; Liu Y; Wang R
J Orthop Surg Res; 2023 Dec; 18(1):985. PubMed ID: 38129870
[TBL] [Abstract] [Full Text] [Related]
3. cxcr4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.
Hartlapp I; Hartrampf PE; Serfling SE; Wild V; Weich A; Rasche L; Roth S; Rosenwald A; Mihatsch PW; Hendricks A; Wiegering A; Wiegering V; Hänscheid H; Schirbel A; Werner RA; Buck AK; Wester HJ; Einsele H; Kunzmann V; Lapa C; Kortüm KM
J Nucl Med; 2023 Sep; 64(9):1424-1430. PubMed ID: 37348915
[TBL] [Abstract] [Full Text] [Related]
4. Animal models of Soft Tissue Sarcoma for alternative anticancer therapy studies: characterization of the A-72 Canine Cell Line.
Razzuoli E; Chirullo B; De Ciucis CG; Mecocci S; Martini I; Zoccola R; Campanella C; Varello K; Petrucci P; Di Meo A; Bozzetta E; Tarantino M; Goria M; Modesto P
Vet Res Commun; 2023 Sep; 47(3):1615-1627. PubMed ID: 37038001
[TBL] [Abstract] [Full Text] [Related]
5. CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death.
Kuehnle N; Osborne SM; Liang Z; Manzano M; Gottwein E
Cell Death Differ; 2023 May; 30(5):1221-1234. PubMed ID: 36801923
[TBL] [Abstract] [Full Text] [Related]
6. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-cxcr4 Axis.
Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
[TBL] [Abstract] [Full Text] [Related]
7.
Watts A; Singh B; Singh H; Kaur H; Bal A; Vohra M; Arora SK; Behera D
J Nucl Med Technol; 2022 Sep; 50(3):278-281. PubMed ID: 35610039
[No Abstract] [Full Text] [Related]
8. Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model: Hoxa11 in myeloid sarcoma formation.
Fu JF; Wen CJ; Yen TH; Shih LY
Neoplasia; 2022 Jul; 29():100802. PubMed ID: 35500545
[TBL] [Abstract] [Full Text] [Related]
9. Unraveling the IGF System Interactome in sarcomas Exploits Novel Therapeutic Options.
Mancarella C; Morrione A; Scotlandi K
Cells; 2021 Aug; 10(8):. PubMed ID: 34440844
[TBL] [Abstract] [Full Text] [Related]
10. cxcr4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition.
Liao YX; Lv JY; Zhou ZF; Xu TY; Yang D; Gao QM; Fan L; Li GD; Yu HY; Liu KY
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34080667
[TBL] [Abstract] [Full Text] [Related]
11. Vincetoxicum arnottianum modulates motility features and metastatic marker expression in pediatric rhabdomyosarcoma by stabilizing the actin cytoskeleton.
Adamus A; Ali I; Vasileiadis V; Al-Hileh L; Lisec J; Frank M; Seitz G; Engel N
BMC Complement Med Ther; 2021 May; 21(1):136. PubMed ID: 33947373
[TBL] [Abstract] [Full Text] [Related]
12. Development of
Trujillo-Nolasco M; Cruz-Nova P; Ferro-Flores G; Gibbens-Bandala B; Morales-Avila E; Aranda-Lara L; Vargas M; Ocampo-García B
J Biomed Nanotechnol; 2021 Feb; 17(2):263-278. PubMed ID: 33785097
[TBL] [Abstract] [Full Text] [Related]
13. The effect of microRNA-330 replacement on inhibition of growth and migration in renal cancer cells.
Liu J; Song X; Ren Z
Biotechnol Appl Biochem; 2022 Apr; 69(2):558-566. PubMed ID: 33605482
[TBL] [Abstract] [Full Text] [Related]
14. The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene cxcr4, stem cell regulatory genes and self-renewal.
Sarkhosh-Inanlou R; Imani M; Sam MR
Biomed Pharmacother; 2020 Dec; 132():110807. PubMed ID: 33068939
[TBL] [Abstract] [Full Text] [Related]
15. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells.
Bazavar M; Fazli J; Valizadeh A; Ma B; Mohammadi E; Asemi Z; Alemi F; Maleki M; Xing S; Yousefi B
Pathol Res Pract; 2020 Nov; 216(11):153176. PubMed ID: 32861171
[TBL] [Abstract] [Full Text] [Related]
16. Cytotoxic drugs in combination with the cxcr4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
[TBL] [Abstract] [Full Text] [Related]
17. Expression of cxcr4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.
Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH
Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Significance of Cancer Stem Cell Markers CD133 and cxcr4 in Osteosarcomas.
Mardani A; Gheytanchi E; Mousavie SH; Madjd Jabari Z; Shooshtarizadeh T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):67-73. PubMed ID: 31983166
[TBL] [Abstract] [Full Text] [Related]
19. The Role of C-X-C Chemokine Receptor Type 4 (cxcr4) in Cell Adherence and Spheroid Formation of Human Ewing's Sarcoma Cells under Simulated Microgravity.
Romswinkel A; Infanger M; Dietz C; Strube F; Kraus A
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810195
[TBL] [Abstract] [Full Text] [Related]
20. CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma.
Tang Y; Gu Z; Fu Y; Wang J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696204
[TBL] [Abstract] [Full Text] [Related]
[Next]